Prognostic factors of disability progression in multiple sclerosis in real life: the OFSEP-high definition (OFSEP-HD) prospective cohort in France.

Date publication

avril 2025

Journal

BMJ open

Auteurs

Membres identifiés du Cancéropôle Est :
Pr GUILLEMIN Francis

Tous les auteurs :
Guillemin F, Casey R, Epstein J, Foucher Y, Laplaud D, Achit H, Rollot F, Leray E, Vukusic S,

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/40194873

Résumé

To determine prognostic factors of disability in multiple sclerosis (MS), that is, (1) identify determinants of the dynamics of disability progression; (2) study the effectiveness of disease-modifying treatments (DMTs); (3) merge determinants and DMTs for creating patient-centred prognostic tools and (4) conduct an economic analysis.

Mots clés

Disabled Persons, Multiple sclerosis, Patient Reported Outcome Measures, Prognosis

Référence

BMJ Open. 2025 04 7;15(4):e094688